Compare ImmunityBio Inc. Common Stock (IBRX) vs Wolfspeed Inc (WOLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Wolfspeed Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $10.51 (market cap $10.51B), while Wolfspeed Inc trades at $30.54 (market cap $1.64B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 6.4× Wolfspeed Inc's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Wolfspeed Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Wolfspeed Inc for 19 Days on average.
| IBRX | WOLF | |
|---|---|---|
Market Cap | $10.51B | $1.64B |
Volume | 10,445,785 | 22,772,687 |
Sector | Health | Technology |
52-Week High | $11.55 | $73.68 |
52-Week Low | $1.98 | $14.80 |
Typical Hold Time | 1 Days | 19 Days |
Enterprise Value | $10.97B | $2.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Wolfspeed (WOLF) trades at $31.02, down 1.12% today, showing mixed technical signals with a bullish moving average trend but neutral oscillators. The company faces significant fundamental challenges with negative gross margins (-16.05%) and substantial net losses (-$1.61B in 2025), though 2026 projections show potential for profitability. Recent developments include expansion of 200mm silicon carbide technology, positioning the company in the growing AI infrastructure sector.
The stock presents a high-risk, high-reward opportunity with analyst consensus target of $54.32 suggesting 75% upside potential. Key catalysts include revenue growth from AI infrastructure demand and operational improvements, while risks involve ongoing losses, competitive pressures, and multiple ongoing investor investigations that could create volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Wolfspeed Inc
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →
